Search by Drug Name or NDC
NDC 62135-0054-90 Doxazosin mesylate 8 mg/1 Details
Doxazosin mesylate 8 mg/1
Doxazosin mesylate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Chartwell RX, LLC. The primary component is DOXAZOSIN MESYLATE.
MedlinePlus Drug Summary
Doxazosin is used in men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia or BPH), which include difficulty urinating (hesitation, dribbling, weak stream, and incomplete bladder emptying), painful urination, and urinary frequency and urgency. It is also used alone or in combination with other medications to treat high blood pressure. Doxazosin is in a class of medications called alpha-blockers. It relieves the symptoms of BPH by relaxing the muscles of the bladder and prostate. It lowers blood pressure by relaxing the blood vessels so that blood can flow more easily through the body. High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 62135-0054-90Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Doxazosin
Product Information
| NDC | 62135-0054 |
|---|---|
| Product ID | 62135-054_fdb507a5-0211-0689-e053-6394a90a860a |
| Associated GPIs | |
| GCN Sequence Number | 015587 |
| GCN Sequence Number Description | doxazosin mesylate TABLET 8 MG ORAL |
| HIC3 | J7B |
| HIC3 Description | ALPHA-ADRENERGIC BLOCKING AGENTS |
| GCN | 33434 |
| HICL Sequence Number | 006031 |
| HICL Sequence Number Description | DOXAZOSIN MESYLATE |
| Brand/Generic | Generic |
| Proprietary Name | Doxazosin mesylate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Doxazosin mesylate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 8 |
| Active Ingredient Units | mg/1 |
| Substance Name | DOXAZOSIN MESYLATE |
| Labeler Name | Chartwell RX, LLC |
| Pharmaceutical Class | Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA075646 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 62135-0054-90 (62135005490)
| NDC Package Code | 62135-054-90 |
|---|---|
| Billing NDC | 62135005490 |
| Package | 90 TABLET in 1 BOTTLE (62135-054-90) |
| Marketing Start Date | 2023-06-06 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |